机译:儿茶酚-O-甲基转移酶Val 108/158 Met多态性与乳腺癌风险:叙利亚的病例对照研究
Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);
Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);
Pathology Department Faculty of Medicine University of Aleppo">(2);
Oncosurgery Ibn Rushd Hospital">(3);
Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);
Research Cancer Centre of the Syrian Society Against Cancer">(4);
Oncology Department Faculty of Medicine McGill University">(5);
Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);
Breast cancer; Syrian patients; COMT; Val158Met; Polymorphism;
机译:儿茶酚-O-甲基转移酶Val108 / 158Met多态性与乳腺癌风险之间缺乏关联:对25,627例病例和34,222例对照的荟萃分析
机译:绝经前乳腺癌患者的儿茶酚-O-甲基转移酶Val 108/158 Met多态性。
机译:精神分裂症发病年龄和临床症状中儿茶酚-O-甲基转移酶(COMT)Val108 / 158Met与脑源性神经营养因子(BDNF)Val66Met多态性之间的相互作用。
机译:整合了乳腺密度和实质性纹理分析以进行数字化X线检查的全自动软件管道:病例对照乳腺癌风险评估研究中的参数优化
机译:儿茶酚-O-甲基转移酶多态性:对儿茶酚雌激素甲基化和乳腺癌风险的影响
机译:儿茶酚-O-甲基转移酶Val158Met多态性有助于中国人群患乳腺癌的风险:最新的荟萃分析
机译:酒精依赖患者功能性儿茶酚-O-甲基转移酶(COMT)Val108 / 158Met多态性与自杀企图的关联研究